XML 39 R32.htm IDEA: XBRL DOCUMENT v3.25.3
Basis of Presentation and Significant Accounting Policies - Schedule of Revenues consist of product sales to customers (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Disaggregation of Revenue [Line Items]        
Total revenues $ 278,633 $ 250,401 $ 787,516 $ 698,195
NUPLAZID        
Disaggregation of Revenue [Line Items]        
Total revenues 177,530 159,186 505,730 446,518
DAYBUE        
Disaggregation of Revenue [Line Items]        
Total revenues $ 101,103 $ 91,215 $ 281,786 $ 251,677